Premium
Safety and efficacy of COVID‐19 convalescent plasma in severe pulmonary disease: A report of 17 patients
Author(s) -
Pal Priya,
Ibrahim Moayed,
Niu Alex,
Zwezdaryk Kevin J.,
Tatje Elise,
Robinson William R.,
Ko Leta,
Satyavarapu Ishwarya,
Jones Wallace E.,
Nachabe Adeem,
Luk Alfred,
Mushatt David M.,
Halvorson Karin,
Denson Joshua L.,
Smith Charles C.,
Simeone Francesco,
Davis Gaynelle,
Gill Sukhmani K.,
McDougal April,
Vigh Aniko S.,
Peterson Tim G.,
Ning Bo,
Hu Tony,
Socola Francisco,
Robinson James,
Safah Hana,
Saba Nakhle S.
Publication year - 2021
Publication title -
transfusion medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.471
H-Index - 59
eISSN - 1365-3148
pISSN - 0958-7578
DOI - 10.1111/tme.12729
Subject(s) - medicine , hydroxychloroquine , convalescent plasma , case fatality rate , lopinavir , convalescence , ritonavir , asymptomatic , pandemic , pneumonia , intensive care medicine , immunology , covid-19 , disease , epidemiology , virus , viral load , infectious disease (medical specialty) , antiretroviral therapy